About Shalby Ltd
Shalby operates as a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations etc.
Founded
2004
CEO
Vikram Shah
Employees
2,838
HQ
Ahmedabad, India
Finished Products
1Sale of Services
₹1,580.08Cr2Sale of License
₹892.33Cr3Allied Service
₹46.19Cr4Out Patient Discharge
₹33.41Cr5Medicines & Medicare Items
₹19.45Cr6Hospital Services
₹17.06Cr7Other Operating Revenue
₹12.42CrRaw Materials
1Medicines and Medicare Items
₹25.40Cr2Purchase of Traded goods
₹10.51CrAbout Shalby Ltd
Shalby operates as a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations etc.
Founded:2004
CEO:Vikram Shah
Employees:2,838
HQ:Ahmedabad, India
Finished Products
1Sale of Services
₹1,580.08Cr2Sale of License
₹892.33Cr3Allied Service
₹46.19Cr4Out Patient Discharge
₹33.41Cr5Medicines & Medicare Items
₹19.45Cr6Hospital Services
₹17.06Cr7Other Operating Revenue
₹12.42CrRaw Materials
1Medicines and Medicare Items
₹25.40Cr2Purchase of Traded goods
₹10.51CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹275
52W Low
₹126
Volume95.39K
Avg VolumeN/A
Beta1.39
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
44.45x
Valuation
P/B Ratio
1.66x
Valuation
EPS
₹3.47
Valuation
Dividend Yield
0.00%
Valuation
ROE
3.72%
Profitability
ROCE
6.20%
Profitability
Revenue by Segment
Contribution & growth by business line
Healthcare Services
+3.1%88.5%
₹1,010.14 Cr
Manufacturing & Trading of Implants
+22.5%11.5%
₹131.29 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.59x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.